Abstract
Aim:
The human cytochrome P450 2D6 (CYP2D6) gene copy number variation, involving CYP2D6 gene deletion (CYP2D6*5) and duplication or multiduplication (CYP2D6*×N), can result in reduced or increased metabolism of many clinically used drugs. The identification of CYP2D6*5 and CYP2D6*×N and the investigation of their allelic distributions in ethnic populations can be important in determining the right drug and dosage for each patient.
Methods:
The CYP2D6*5 and CYP2D6 genes, and CYP2D6 gene duplication were identified by 2 modified long PCR, respectively. To determine duplicated alleles, a novel long PCR was developed to amplify the entire duplicated CYP2D6 gene which was used as template for subsequent PCR amplification. A total of 363 unrelated Eastern Han Chinese individuals were analyzed for CYP2D6 gene copy number variation.
Results:
The frequency of CYP2D6*5 and CYP2D6*×N were 4.82% (n=35) and 0.69% (n=5) in the Eastern Han Chinese population, respectively. Of the 5 duplicated alleles, 3 were CYP2D6*1×N and 2 were CYP2D6*10×N. One individual was a carrier of both CYP2D6*5 and CYP2D6*1×N. Taken together, the CYP2D6 gene rearrangements were present in 10.74% of subjects.
Conclusion:
Allelic distributions of the CYP2D6 gene copy number variation differ among Chinese from different regions, indicating ethnic variety in Chinese. Long PCR are convenient, cost effective, specific and semiquantitative for the detection of the CYP2D6 gene copy number variation, and amplification of the entire duplicated CYP2D6 gene is necessary for the accurate identification of duplicated alleles.
Similar content being viewed by others
Article PDF
References
Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW . Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 2004; 14: 1–18.
Wilkinson GR . Drug metabolism and variability among patients in drug response. N Engl J Med 2005; 352: 2211–21.
The Human Cytochrome P450 (CYP) Allele Nomenclature committee tHCPCAN. [Updated 2006 May 17, cited 2006 Jun 15] Available from: http://www.cypalleles.ki.se/cyp2d6.htm.
Ingelman-Sundberg M . The human genome project and novel aspects of cytochrome P450 research. Toxicol Appl Pharmacol 2005; 207: 52–6.
Bertilsson L, Dahl ML, Dalen P, Al-Shurbaji A . Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs. Br J Clin Pharmacol 2002; 53: 111–22.
Gaedigk A, Gotschall RR, Forbes NS, Simon SD, Kearns GL, Leeder JS . Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data. Pharmacogenetics 1999; 9: 669–82.
Garcia-Barcelo M, Chow LY, Chiu HF, Wing YK, Lee DT, Lam KL, et al. Genetic analysis of the CYP2D6 locus in a Hong Kong Chinese population. Clin Chem 2000; 46: 18–23.
Ismail R, Teh LK, Amir J, Alwi Z, Lopez CG . Genetic polymorphism of CYP2D6 in Chinese subjects in Malaysia. J Clin Pharm Ther 2003; 28: 279–84.
Ingelman-Sundberg M . Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J 2004; 5: 6–13.
Ji L, Pan S, Marti-Jaun J, Hanseler E, Rentsch K, Hersberger M . Single-step assays to analyze CYP2D6 gene polymorphisms in Asians: allele frequencies and a novel *14B allele in mainland Chinese. Clin Chem 2002; 48: 983–8.
Johansson I, Oscarson M, Yue QY, Bertilsson L, Sjoqvist F, Ingelman-Sundberg M . Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation. Mol Pharmacol 1994; 46: 452–9.
Soderback E, Zackrisson AL, Lindblom B, Alderborn A . Determination of CYP2D6 gene copy number by pyrosequencing. Clin Chem 2005; 51: 522–31.
Lundqvist E, Johansson I, Ingelman-Sundberg M . Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes. Gene 1999; 226: 327–38.
Nevilie M, Selzer R, Aizenstein B, Maguire M, Hogan K, Walton R, et al. Characterization of cytochrome P450 2D6 alleles using the Invader system. Biotechniques 2002; Suppl: 34–38, 40–43.
Muller B, Zopf K, Bachofer J, Steimer W . Optimized strategy for rapid cytochrome P450 2D6 genotyping by real-time long PCR. Clin Chem 2003; 49: 1624–31.
Bodin L, Beaune PH, Loriot MA . Determination of cytochrome P450 2D6 (CYP2D6) gene copy number by real-time quantitative PCR. J Biomed Biotechnol 2005; 2005: 248–53.
Schaeffeler E, Schwab M, Eichelbaum M, Zanger UM . CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR. Hum Mutat 2003; 22: 476–85.
Hersberger M, Marti-Jaun J, Rentsch K, Hanseler E . Rapid detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 alleles by tetra-primer PCR and of the CYP2D6*5 allele by multiplex long PCR. Clin Chem 2000; 46: 1072–7.
Steen VM, Andreassen OA, Daly AK, Tefre T, Borresen AL, Idle JR, et al. Detection of the poor metabolizer-associated CYP2D6 (D) gene deletion allele by long-PCR technology. Pharmacogenetics 1995; 5: 215–23.
Lovlie R, Daly AK, Molven A, Idle JR, Steen VM . Ultrarapid metabolizers of debrisoquine: characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene. FEBS Lett 1996; 392: 30–4.
Dorado P, Caceres MC, Pozo-Guisado E, Wong ML, Licinio J, Llerena A . Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use. Biotechniques 2005; 39: 571–4.
Johansson I, Lundqvist E, Bertilsson L, Dahl ML, Sjoqvist F, Ingelman-Sundberg M . Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine. Proc Natl Acad Sci USA 1993; 90: 11825–9.
Ma MK, Woo MH, McLeod HL . Genetic basis of drug metabolism. Am J Health Syst Pharm 2002; 59: 2061–9.
Johansson I, Lundqvist E, Dahl ML, Ingelman-Sundberg M . PCR-based genotyping for duplicated and deleted CYP2D6 genes. Pharmacogenetics 1996; 6: 351–5.
Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS . ‘Touchdown’ PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 1991; 19: 4008.
Ledesma MC, Agundez JA . Identification of subtypes of CYP2D gene rearrangements among carriers of CYP2D6 gene deletion and duplication. Clin Chem 2005; 51: 939–43.
McCarroll SA, Hadnott TN, Perry GH, Sabeti PC, Zody MC, Barrett JC, et al. Common deletion polymorphisms in the human genome. Nat Genet 2006; 38: 86–92.
Hinds DA, Kloek AP, Jen M, Chen X, Frazer KA . Common deletions and SNPs are in linkage disequilibrium in the human genome. Nat Genet 2006; 38: 82–5.
Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, et al. Detection of large-scale variation in the human genome. Nat Genet 2004; 36: 949–51.
Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, et al. Large-scale copy number polymorphism in the human genome. Science 2004; 305: 525–8.
Sharp AJ, Locke DP, McGrath SD, Cheng Z, Bailey JA, Vallente RU, et al. Segmental duplications and copy-number variation in the human genome. Am J Hum Genet 2005; 77: 78–88.
Feuk L, Marshall CR, Wintle RF, Scherer SW . Structural variants: changing the landscape of chromosomes and design of disease studies. Hum Mol Genet 2006; 15: R57–66.
Wang SL, Lai MD, Huang JD . G169R mutation diminishes the metabolic activity of CYP2D6 in Chinese. Drug Metab Dispos 1999; 27: 385–8.
Ishiguro A, Kubota T, Sasaki H, Iga T . A long PCR assay to distinguish CYP2D6*5 and a novel CYP2D6 mutant allele associated with an 11-kb EcoRI haplotype. Clin Chim Acta 2004; 347: 217–21.
Fukuda T, Maune H, Ikenaga Y, Naohara M, Fukuda K, Azuma J . Novel structure of the CYP2D6 gene that confuses genotyping for the CYP2D6*5 allele. Drug Metab Pharmacokinet 2005; 20: 345–50.
Juran BD, Egan LJ, Lazaridis KN . The AmpliChip CYP450 Test: principles, challenges, and future clinical utility in digestive disease. Clin Gastroenterol Hepatol 2006; 4: 822–30.
Gaedigk A, Bradford LD, Alander SW, Leeder JS . CYP2D6*36 gene arrangements within the CYP2D6 locus: association of CYP2D6*36 with poor metabolizer status. Drug Metab Dispos 2006; 34: 563–9.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by grants from the Shanghai Science and Technology Committee Fund (No 05dz52022 and No 05dz19318).
Rights and permissions
About this article
Cite this article
Sheng, Hh., Zeng, Ap., Zhu, Wx. et al. Allelic distributions of CYP2D6 gene copy number variation in the Eastern Han Chinese population. Acta Pharmacol Sin 28, 279–286 (2007). https://doi.org/10.1111/j.1745-7254.2007.00479.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00479.x